Use of antibiotics in health care and problems with AMR in Estonia: comparison with Europe

Presentation given during Cost AMiCI meeting in Tallinn Nov 2017 by Irja Lutsar MD, PhD Professor of Medical Microbiology  University of Tartu  

Join first virtual AMiCI update on Feb 1st by Francy an Minna

It bacame aparent that lot of AMiCI members would like to be more informed and involved in our Action. The possibility of giving updates, and even lectures through the virtual HILL system, available via SAMK has been discussed during last meeting in Tallin. Now it has come to reality: Minna and Francy will explore this possibility by giving first virtual AMiCI update through the virtual HILL

Antimicrobial Activity Testing of Orthopedic Implant Surface

Applications are open for The COST Training School on   Standardized Antimicrobial Activity Testing of Orthopedic Implant Surface planned March 21-23, Université Libre de Bruxelles, Belgium.   The training is organized by Université Libre de Bruxelles (ULB) Faculty of Pharmacy Microbiology, Bioorganic and Macromolecular Chemistry unit Campus Plaine in he scope of COST Action TD1305 Improved Protection of Medical Devices Against Infection (IPROMEDAI). The three days program: Day 1: – Aseptic processing and environmental conditions, – Preparation of the surfaces for the assay, – Preparation of

Joint seminar of the COST AMiCI Action Core Group and WG3 held in NICPB, Tallinn, Estonia

On 16th-17th November 2017, the joint seminar of the COST AMICI Network Core Group and the Working Group 3 was held in the National Institute of Chemical Physics and Biophysics, Tallinn, Estonia. The European Union COST Action AMICI  brings together experts on the synthesis, use and assessment of unwanted side effects of antimicrobial coatings. The project is coordinated by dr.  Francy Crijns (Zuyd University of

AMiCI on 10th Congress of Toxicology in Developing Countries (Belgrade, Serbia)

The Symposium “Antimicrobial coatings in healthcare settings: efficiency versus safety” Infections and infectious diseases are considered a major challenge to human health in healthcare units worldwide. As antimicrobial materials (such as silver and copper) are inherently toxic, the application of (nano-enabled) antimicrobial surface coatings (AMCs) in healthcare settings may cause harm in addition to benefits. Indeed, in parallel to cutting down the spread of potentially

Proactive Approach for Safe Use of Antimicrobial Coatings in Healthcare Settings

First opinion paper of the COST Action Network AMiCI have been published in The International Journal of Environmental Research and Public Health. We publish here the abstract (1) and  conclusions (5). 1.The abstract: Infections and infectious diseases are considered a major challenge to human health in healthcare units worldwide. This opinion paper was initiated by EU COST Action network AMiCI (AntiMicrobial Coating Innovations) and focuses on scientific information essential

The AMiCI COST Action on 2017 ECSJ in Copenhagen

The AMiCI Action has been selected, as one of 10 COST Actions, to be presented on this year’s European Conference for Science Journalists (Copenhagen, 26-30 June), the largest gathering of science journalists in Europe in 2017. This is a great chance to communicate about the issue and how important collaborative science is in the society. Antimicrobial Coatings as Weapon Against Infectious Diseases HealthCare Associated Infections (HAI) are

COST multidisciplinary European research networks are key to FP9

On 15 June, the COST Committee of Senior Officials (CSO) published its position paper, highlighting the importance of multidisciplinary, bottom-up, open and inclusive networks, pleading for sufficient funding post Horizon 2020. Investment in research and innovation is key for the EU to realise its ambition of becoming a smart, sustainable and inclusive economy and to contribute to the well-being of society. Therefore, EU policy makers

Pori Ready to Welcome Participants of AMiCI meeting (June 6-8th)

Pori is ready to welcome participants of the second COST Action AMiCI conference. The final program of the meeting: Day 1 (6th of June) The Conference ‘Antimicrobial coatings in healthcare: from innovation to the market’. Key-note speakers will cover issues along the AMC value chain; from patents, regulatory, implementation in hospitals, to evaluation of the impact taken from a real life example. The conference will

Second AMiCI Conference planned for June 6-8 in Pori (Finland)

Based on lessons learnt from the AMiCI meeting in Heerlen (November 2016), the focus of the second meeting, planned in June 2017 in Pori (Finland), will move to the expertise within the working groups. The framework program of the meeting: Day 1 (6th of June) The Conference ‘Antimicrobial coatings in healthcare: from innovation to the market’. Key-note speakers will cover issues along the AMC value